- Corporate Officers - L
- Lucas Svetlana
Insider Trading History of Lucas Svetlana
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lucas Svetlana since 2023.
This trader's CIK number is 1781292.
At the time of last reporting, Lucas Svetlana was the Chief Business Officer of Scribe Therapeutics, Inc.. (stock ticker symbol SCTX).
Also see all insider trading activities at Scribe Therapeutics, Inc..
Note that in the past
Lucas Svetlana also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Scribe Therapeutics, Inc. (SCTX) by Lucas Svetlana
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | SCTX | 3,000 | $45,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Jasper Therapeutics, Inc. (JSPR) by Lucas Svetlana
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | JSPR | 20,000 | $48,600 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Atyr Pharma Inc (LIFE) by Lucas Svetlana
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | LIFE | 0 | $0 | 0 | $0 | 6,000 | $0 |
Insider trading activities at 3 companies by Lucas Svetlana:
1. Scribe Therapeutics, Inc. (SCTX)
2. Jasper Therapeutics, Inc. (JSPR)
3. Atyr Pharma Inc (LIFE)
Table 1. Insider trading of Scribe Therapeutics, Inc. (SCTX) by Lucas Svetlana
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-07-23 | SCTX | Buy | 3,000 | 15.00 | 45,000 |
Table 2. Insider trading of Jasper Therapeutics, Inc. (JSPR) by Lucas Svetlana
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-09-22 | JSPR | Buy | 20,000 | 2.43 | 48,600 |
Table 3. Insider trading of Atyr Pharma Inc (LIFE) by Lucas Svetlana
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-04-26 | LIFE | Option Ex | 6,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Lucas Svetlana
(Chief Business Officer of Scribe Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.